A Phase 3, Randomized, Global Trial of Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in First-line Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
Phase of Trial: Phase III
Latest Information Update: 18 Dec 2018
At a glance
- Drugs Epacadostat (Primary) ; Nivolumab (Primary) ; Carboplatin; Cisplatin; Gemcitabine; Paclitaxel; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Sponsors Incyte Corporation
- 18 Jul 2018 Status changed from active, no longer recruiting to discontinued.
- 14 May 2018 Planned End Date changed from 1 Apr 2022 to 1 Jun 2018.
- 14 May 2018 Planned primary completion date changed from 1 Mar 2021 to 1 Jun 2018.